AI flow cytometry analysis has become the default approach for cell population discovery once a panel outgrows what a scientist can gate by eye. Manual gating does not scale to today's high-parameter ...
In the near future, clinical trials will use machine learning routinely to analyze data. Today, however, machine learning is still at an adoption midpoint—no longer pioneering, but not yet ubiquitous.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results